References
- Ali NA, O'Brien JM, Blum W, et al (2007). Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality. Cancer, 110, 96-102. https://doi.org/10.1002/cncr.22777
- Belgaumi AF, Al-Bakrah M, Al-Mahr M, et al (2003). Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin. Cancer, 97, 2898-903. https://doi.org/10.1002/cncr.11390
- Bochicchio GV, Bochicchio KM, Joshi M, et al (2010). Acute glucose elevation is highly predictive of infection and outcome in critically injured trauma patients. Ann Surg, 252, 597-602.
- Brown VI, Seif AE, Reid GS, et al (2008). Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease. Immunol Res, 42, 84-105. https://doi.org/10.1007/s12026-008-8038-9
- Devos P, Preiser JC (2004). Tight blood glucose control: a recommendation ap-plicable to any critically ill patient? Crit Care, 8, 427-9. https://doi.org/10.1186/cc2989
- Faustino EV, Apkon M (2005). Persistent hyperglycemia in critically ill chil dren. J Pediatr, 146, 30-4. https://doi.org/10.1016/j.jpeds.2004.08.076
- Feng YH, Velazquez-Torres G, Gully C, et al (2011). The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth. J Cell Mol Med, 15, 825-36. https://doi.org/10.1111/j.1582-4934.2010.01083.x
- Hunger SP, Lu X, Devidas M, et a1 (2012). Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. J Clin Oncol, 30, 1663-9. https://doi.org/10.1200/JCO.2011.37.8018
- Lowas SR, Marks D and Malempati S (2009). Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer, 52, 814-8. https://doi.org/10.1002/pbc.21980
- Pan JX, Chen C, Jin, Y, et al (2012). Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells. Cell Cycle, 11, 2314-26. https://doi.org/10.4161/cc.20770
- Roberson JR, Raju S, Shelso J, et al (2008). Diabetic ketoacidosis during therapy for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer, 50, 1207-12. https://doi.org/10.1002/pbc.21505
- Roberson JR, Spraker HL, Shelso J, et al (2009). Clinical consequences of hyperglycemia during remission induction therapy for pediatric acute lymphoblastic leukemia. Leukemia, 23, 245-50. https://doi.org/10.1038/leu.2008.289
- Seshasai SR, Kaptoge S, Thompson A, et al (2011). Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose and risk of cause-specific death. N Engl J Med, 364, 829-41. https://doi.org/10.1056/NEJMoa1008862
- Sonabend RY, McKay SV, Okcu M, et al (2009). Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia. J Pediatr, 155, 73-8. https://doi.org/10.1016/j.jpeds.2009.01.072
- Sonabend RY, McKay SV, Okcu MF, et al (2008). Hyperglycemia during induction therapy is associated with increased infectious complications in childhood acute lymphocytic leukemia. Pediatr Blood Cancer, 51, 387-92. https://doi.org/10.1002/pbc.21624
- Spinola-Castro AM, Siviero-Miachon AA, Andreoni S, et al (2009). Transient hyperglycemia during childhood acute lymphocytic leukemia chemotherapy: an old event revisited. Clin Adv Hematol Oncol, 7, 465-72.
- Vu K, Busaidy N, Cabanillas ME, et al (2012). A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk, 12, 355-62. https://doi.org/10.1016/j.clml.2012.05.004
- Weiser MA, Cabanillas ME, Konopleva M, et al (2004). Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with ahyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytar-abine regimen. Cancer, 100, 1179-85. https://doi.org/10.1002/cncr.20071
- Yeung SJ, Pan J and Lee MH (2008). Roles of p53, MYC and HIF-1 in regulating glycolysis-the seventh hallmark of cancer. Cell Mol Life Sci, 65, 3981-99. https://doi.org/10.1007/s00018-008-8224-x
Cited by
- Evaluation of Insulin-mediated Regulation of AKT Signaling in Childhood Acute Lymphoblastic Leukemia vol.41, pp.2, 2019, https://doi.org/10.1097/MPH.0000000000001425